
About
XPAMAC Inc. is a biotechnology startup based in Szeged, Hungary. It offers cell line development services and intracellular protein delivery technology for biotech, biopharma, and CDMO partners working on therapeutic proteins and other difficult-to-express biologics.
Services
Custom Cell Line Development
Develops stable mammalian cell lines using the proprietary XPAMAC technology for protein production.
Cell line development
Protein Production
Supports production of therapeutic proteins using XPAMAC-developed cell lines.
Protein production
Intracellular Protein Therapeutics (IPT) platform
Converts therapeutic proteins such as antibodies, intrabodies, and nanobodies for cytosolic delivery at nanomolar concentrations.
Cell line development based on Mammalian Elongated Chromosome (MEC)
Creates stable, silencing-free mammalian cell lines with targeted integration and gene amplification.
Cell line development
Production of rAAV-producing stable cell lines
Develops stable cell lines for advanced gene therapies.
Cell line development
Development of a complement inhibitor (Factor-H) cartridge
Develops a Factor-H cartridge related to complement inhibition.
Platform for delivering therapeutic proteins into the cytosol
Provides a receptor-based delivery approach intended to move protein cargo into the cytosol without chemical modification of the cargo.
- Turnaround
- 8 weeks · Within 8 weeks
- What to send
- Plasmid DNA
Capabilities
- Assays and studies
- Antibodies · CHO · HEK293 · Protein expression · Cell line development · Intracellular delivery · Cytosolic delivery · Endocytosis
- Scale and capacity
- Transgene copy numbers in the range of 1-100 · Cell line development within 8 weeks
- Therapeutic areas
- Biologics · Protein therapeutics · Gene therapies · Biologics development
Modalities and species
- Modalities
- Antibody · Viral vector · Cell therapy · Recombinant protein
- Species and models
- CHO-K1 · CHO-DG44 · HEK293 · CHO · Human cell lines
Industries served
- Biotech
- Biopharma
- CDMOs
- Research centers
Company
- Founded
- 2022
- Team
- 10+ employees
- Quality
- Patent applications worldwide (XPAMAC gene integration and amplification technology) · patent filed (tag-triggered cytosolic delivery of macromolecules)
Locations
- Based in
- Szeged, Hungary
- Sites
- Szeged, Hungary
- Serves
- international
Similar labs
Work here? Claim this listing